Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques
This study is currently recruiting participants.
Verified by Centers for Disease Control and Prevention, June 2007
Sponsored by: Centers for Disease Control and Prevention
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00252083
  Purpose

This study will look at the following questions:

  • Was there a significant difference in HIV prevention knowledge, risk reduction attitudes, norms, intentions, self efficacy, number of sexual partners, and incidence of unprotected anal intercourse among seropositive Hispanic men who have sex with men (MSM) after the implementation of ADAPT-POL?

Hypothesis: There will be a significant increase in HIV prevention knowledge, intentions, and self efficacy concerning condom use. There will be a decrease in risk attitudes, norms, number of sexual partners, and incidence of unprotected anal intercourse among seropositive Hispanic MSM after the implementation of ADAPT-POL.

  • How is exposure to the intervention and intervention dosage related to the following variables: HIV prevention knowledge, attitudes, intentions, and behaviors concerning unprotected anal intercourse?

Hypothesis: Intervention exposure and dosage are positively correlated with improved HIV prevention knowledge, attitudes, intentions, and behaviors concerning unprotected anal intercourse.


Condition Intervention
HIV Infections
Behavioral: Popular Opinion Leader

MedlinePlus related topics: AIDS
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Double-Blind, Dose Comparison, Parallel Assignment, Efficacy Study
Official Title: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques With Popular Opinion Leader (ADAPT-POL)

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • reduced incidence of unprotected anal intercourse [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • reduced number of sexual partners engaging in unprotected anal intercourse [ Time Frame: 6 months ]

Estimated Enrollment: 200
Study Start Date: July 2004
Estimated Study Completion Date: June 2007
Detailed Description:

The proposed project, Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), has two main goals: first, to assist the Centers for Disease Control and Prevention (CDC) to better understand the processes needed for adapting evidence-based behavioral interventions to fit new conditions or target populations; second, to utilize the CDC’s draft adaptation guidance to adapt Jeff Kelly’s Popular Opinion Leader (POL) for use with adult, seropositive Hispanic men who have sex with other men (MSM). The target population will directly participate in all phases of the intervention adaptation process.

ADAPT, known as ADAPT-POL in El Paso, will include formative research and outcome monitoring. Throughout both periods, the ADAPT-POL staff will conduct process monitoring and evaluation to assess the delivery of the intervention, and to help the CDC understand how the draft adaptation guidance procedures work in a real world setting. Representatives of the target population will participate in focus groups, key informant interviews, and community advisor meetings during the formative phase; and potentially serve as popular opinion leaders (POLs) during the implementation phase.

The knowledge obtained during the ADAPT-POL intervention will be diffused to other interventions and programs at the Planned Parenthood Center of El Paso (PPCEP). This will allow PPCEP management and staff to make informed decisions about the adoption of interventions and what steps might be necessary to adapt existing and future PPCEP interventions that target Hispanic populations. At the conclusion of ADAPT activities, the CDC-developed draft adaptation guidance will be revised based on lessons learned.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • HIV seropositive
  • Men who have sex with other men
  • Sexual contact to orgasm with a man within past year
  • Hispanic
  • At least 18 years of age
  • Those who frequent viable venues for recruiting pre-and post-implementation questionnaire respondents.

Exclusion Criteria:

  • MSM who are not willing to identify themselves to study staff as seropositive Hispanic MSM may be excluded.
  • Those under 18 years of age will be excluded from participation due to the study design precluding direct applicability of hypotheses and intervention to both adults and children due to different cognitive development, HIV prevalence levels, and social networks.
  • Serious mental illness which makes the individual unsuitable for participation
  • Under the influence of drugs or alcohol which makes the individual unsuitable for participation
  • Anyone who does not meet the inclusion criteria
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00252083

Contacts
Contact: Vel S. McKleroy, MPH, BSW 404-639-2982 vmckleroy@cdc.gov
Contact: Jennifer Galbraith, PhD 404-639-8649 jgalbraith@cdc.gov

Locations
United States, Texas
Planned Parenthood Center of El Paso Recruiting
El Paso, Texas, United States, 79902
Contact: Irma Carrillo, MPH     915-544-8195 ext 250     irma.carrillo@ppcep.org    
Contact: Marci Brooks, MA     (915) 544-8195     marci.brooks@ppcep.org    
Principal Investigator: Ferreira-Pinto Joao, PhD            
Sponsors and Collaborators
Investigators
Principal Investigator: Vel S McKleroy, MPH, BSW Centers for Disease Control and Prevention
  More Information

Study ID Numbers: CDC-NCHSTP-U65/CCU623833, U65/CCU623833-01-1
Study First Received: November 10, 2005
Last Updated: June 4, 2007
ClinicalTrials.gov Identifier: NCT00252083  
Health Authority: United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
Seropositive
MSM
Hispanic
Popular Opinion Leader
HIV

Study placed in the following topic categories:
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Retroviridae Infections
Mineral Oil
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on January 14, 2009